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Abstract
Introduction: Adenoid cystic carcinoma is a malignant epithelial neoplasm derived from the salivary
glands. Primary adenoid cystic carcinoma of the cervix is extremely rare, accounting for less than 1%
of all cervical carcinomas. In this paper we report a case of primary adenoid cystic carcinoma and a
review of the related literature.
Case presentation: A 68 year-old woman was admitted with signs and symptoms suggestive of a
cervical cancer. The radiological and pathological investigations confirmed the diagnostic of primary
adenoid cystic carcinoma of the cervix at Stage IIIB according to the International Federation of
Gynaecology and Obstetrics classification. The patient was managed successfully by concurrent
chemo-radiotherapy.
Conclusion: The optimal management of adenoid cystic carcinoma cannot be established for
certain. From our case and from the literature, it appears that combined treatment (surgery,
radiotherapy, and chemotherapy) is necessary for achieving a long-term remission. Concurrent
chemo-radiotherapy appears to be a logical option for locally advanced disease.
Introduction
Adenoid cystic carcinoma (ACC) is a malignant epithelial
neoplasm derived from the salivary glands and can occur
in a variety of other sites. It is characterized by slow growth
and high rate of local recurrence. Metastatic spread is
usually a long-term complication [1]. Primary ACC of the
cervix is extremely rare, accounting for less than 1% of all
cervical carcinomas [1]. The first case was described in
1949 by Paalman [2]. To our knowledge, only 160 cases
have been reported up to 2008. Because of the rarity of the
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We report a case of primary ACC of the cervix and we
discuss briefly the clinical and therapeutic features of the
disease.
Case presentation
A 68 year-old postmenopausal Caucasian woman
(para 10, gravida 10) admitted to our hospital with
spontaneous vaginal bleeding for 6 months. The patient
had never used oral contraceptives or hormone replace-
ments. Gynaecological examination showed an exophytic
ulcerated tumor measuring up to 8cm in the largest
diameter. The lower third of the vagina was involved by
the tumoral process. On bimanual recto-vaginal examina-
tion we showed that the tumour had invaded both sides of
the parametrium. Pelvic computed tomography (CT) scan
showed a heavily cervical mass measuring 6cm × 10cm.
The cervical biopsy was performed. Histological study of
the sampled material showed adenoid cystic carcinoma
infiltration (Figures 1 and 2). CT scan of the chest and
abdomen was normal. The patient was staged IIIB
according to the FIGO classification (classification systems
established by the International Federation of Gynaecol-
ogy and Obstetrics for the staging of gynaecological
cancers). She was managed with concurrent chemotherapy
and photon (25MV) external-beam radiotherapy (RT). The
total dose of RT was 70 Gy delivered in 2 Gy daily fractions
with concurrent weekly cisplatin chemotherapy at a dose
of 40mg/m² iv for 6 cycles. After the treatment completed,
the symptoms disappeared with complete response of the
tumour in physical examination and in CT scan. The
patient, 12 months after the end of chemoradiotherapy,
remains disease free. She is continuously followed by our
group up to now.
Discussion
We report a case of locally advanced ACC of the cervix a
rare malignancy in general. Primary ACC of the cervix
accounts for less than 1% of all cervical carcinomas [1].
The origin of this disease is still unknown. Although,
Human papillomavirus (HPV) infection is believed to be
a necessary cause of cervical cancer, its role in the
pathogenesis of ACC is not well defined [3]. There are
some controversies concerning the epidemiological fea-
tures of this tumor. Our patient was post-menopausal,
Caucasian and multiparous woman. ACC of cervix was
considered as the disease of the postmenopausal women
[4], but more recent data reported some cases in young
woman [5-8]. Although, some authors suggested the
association between ACC, high parity and black race
[4,9], Dixit supported the absence of the observed
relationship [10].
Clinical and radiological characteristics of primary ACC
of the cervix were similar to those of a squamous cell
cancer. The main symptom of disease was the vaginal
bleeding [10]. In the review reported by Dix et al, the
most majority of patients were diagnosed at early stages,
while only 10 cases were diagnosed at stage IIIB and 4 at
stage IV [10].
Because of the rarity of the disease and the absence of
prospective studies, no standard treatment has yet been
proposed. Most patients were treated as squamous cell
Figure 1. Hematoxylin and eosin (HE) staining of the biopsy
specimen, low power view: Proliferation composed of small,
basaloid cells with trabecular structure. Cylindromatous
structures were present. The cribriform pattern was barely
seen with large areas of necrosis.
Figure 2. Hematoxylin and eosin (HE) staining of the biopsy
specimen, high power view.
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combination with adjuvant radiotherapy and/or che-
motherapy, based on the clinical stage and presence of
metastasis. Dixit recommended surgery with adjuvant CRT
for early stage, and CRT in advanced stage [10]. A large
number of chemotherapeutic regimens have been used in
diseasemanagement.Themostusedchemotherapeuticdrug
isCDDPgivenatdose100mg/m².Otherregimenshavebeen
investigated, such as bleomycin, adriamycin and 5 Fluoro-
uracil.Toourknowledge,ourpatientisthe13thStageIIIBof
ACCandthefirstcasesuccessfullymanagedwithconcurrent
CRT. (Table 1) summarizes the clinical findings of majority
of published Stage IIIB ACC of the cervix.
ACC of the cervix seems to be more aggressive than
squamous cell carcinoma of the cervix, with higher
tendency to local and metastatic recurrence even if
diagnosed in their earliest stages [1,17]. Five years and
ten years survival were 37% and 40% respectively [18].
These tumours spread most frequently to the lung, lymph
nodes, abdominal cavity and brain [10]. The prognostic
factors identified were: large tumour diameter, deep
stromal invasion, and presence of tumor cells within a
lymphatic space or capillary/ blood [19]. Consequently,
the authors support the use of multimodality therapy
including surgery, chemotherapy and radiotherapy for
achieving long term remission [10].
Conclusion
In the absence of prospective study, optimal management
for ACC of the cervix cannot be established for certain.
From the literature, it appears that combined treatment is
necessary for achieving cure. Radical surgery with adjuvant
radiotherapy and/or chemotherapy appears to be a logical
option. Concurrent chemo-radiotherapy should also be
considered for locally advanced disease.
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